The Postmenopausal Women - Endotext - NCBI Bookshelf
The menopausal transition marks a time of great variability in reproductive hormones, and this variability can be responsible for specific symptoms, such as hot flashes and mood disturbances. Once a woman who is more than 45 years old has gone for 12 months without a menstrual period, she is considered to be menopausal and has consistently low circulating estradiol and elevated gonadotropins. Estrogen is the most efficacious therapy for bothersome vasomotor symptoms. Although estrogen exerts clear-cut protective effects on the cardiovascular system in premenopausal women, medical evidence does not support its use for the prevention of cardiovascular disease. Estrogen is generally not a first line agent for bone preservation in women without concurrent menopausal symptoms, despite its antiresorptive effects. Non-hormonal alternatives to estrogen and new, tissue specific estrogen complexes (TSECs) are now FDA approved and available for clinical use to treat common menopausal symptoms. For complete coverage of this and all related areas of Endocrinology, please visit our FREE on-line web-textbook, www.endotext.org.
Testosterone and Women
Management of Menopausal Symptoms, PDF, Hot Flash
Paradigm Shift in Pathophysiology of Vasomotor Symptoms: Effects of Estradiol Withdrawal and Progesterone Therapy, PDF, Menopause
Menopause: Paul Beck, MD, FACOG, FACS, PDF, Menopause
Evaluation of Amenorrhea, Anovulation, and Abnormal Bleeding - Endotext - NCBI Bookshelf
Testosterone imbalance may link depression and increased body weight in premenopausal women
Menopause, PDF, Hormone Replacement Therapy (Menopause)
Menopause, PDF, Hormone Replacement Therapy (Menopause)
Evaluation of Amenorrhea, Anovulation, and Abnormal Bleeding - Endotext - NCBI Bookshelf
46,XY Differences of Sexual Development - Endotext - NCBI Bookshelf
Immune System Effects on the Endocrine System - Endotext - NCBI Bookshelf
Menopause, PDF, Hormone Replacement Therapy (Menopause)
Premenstrual Syndrome: A Natural Approach To Management: B J L. M, MD, Facog, PDF, Luteinizing Hormone